Presenter: Dr. James McCormack Dr. Mike Allan Samantha Moe PharmD
In episode 572, James and Mike invite Samantha Moe back to the podcast to go over the evidence around the safety and effectiveness of the monoclonal antibodies used to reduce the risk of respiratory syncytial virus (RSV) infections in infants. We go over all the numbers for hospitalizations and death so you can make evidence-informed…
BS Medicine Episode 630: Vitamin B12 Deficiency: Monthly shots or daily pills?
BS Medicine Episode 629: Deprescribing Cholinesterase Inhibitors: Good or bad idea?
CFP Podcast: Heart of patient-centred care is at home
Presenter(s):
Dr. James McCormack Dr. Mike Allan Samantha Moe PharmD








Please provide any additional comments (optional).